QR kód

A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases

ObjectiveHypertension is a leading global risk factor for disability and death. Irbesartan, a potent angiotensin II receptor blocker, requires continuous safety monitoring. We conducted a disproportionality analysis of irbesartan-related adverse drug events (ADEs) using the FDA’s FAERS and Japan’s J...

Celý popis

Uloženo v:
Hlavní autoři: Qian Liu, Zhiwei Cui, Chao Deng, Chao Yang, Tao Shi
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2024-11-01
Edice:Frontiers in Pharmacology
Témata:
pharmacovigilance
disproportionality analysis
FAERS
JADER
irbesartan
adverse drug events
On-line přístup:https://www.frontiersin.org/articles/10.3389/fphar.2024.1485190/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky